Public-registry site landscape for NCT04082936, a Non-Hodgkin Lymphoma study sponsored by IGM Biosciences, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04082936 (registry record) |
| Sponsor | IGM Biosciences, Inc. |
| Condition(s) | Non-Hodgkin Lymphoma; Follicular Lymphoma; DLBCL; Mantle Cell Lymphoma |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 26 |
| Site countries | United States, Australia, Czechia, France, Italy, South Korea, Spain |
Eichor generates a preliminary site-risk snapshot for NCT04082936 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →